London: A 90-year-old person named Margaret Keenan on Tuesday became the first individual on the planet to receive the Pfizer-BioNTech COVID-19 vaccine as a part of the mass vaccination program being rolled out over the UK.
The injection was given to her at 6.31 GMT – the first of 800,000 portions of the Pfizer/BioNTech vaccine that will be given in the following weeks. Up to four million more are anticipated by the end of the month.
Hubs in the UK will vaccinate over-80s and some health and care workers- the program strives to protect the most vulnerable and permit life to return back to normal.
As indicated by the BBC, Keenan, who turns 91 in the coming week, said it was the “best early birthday present”.
She said: “I feel so privileged to be the 1st person vaccinated against COVID-19, it’s the best early birthday present I could wish for because it means I can finally look forward to spending time with my friends and family in the new year after being on my own for most of the year.”
The UK is the first country on the planet to begin utilizing the Pfizer vaccine after regulators authorized its utilization in the previous week.
Health Secretary Matt Hancock said to BBC Breakfast that there was a long march in front of us but this marks the way out.
"It's just so strange and wonderful really"
Margaret Keenan, who turns 91 next week, says becoming the first to receive the Pfizer/BioNTech vaccine is the "best early birthday present"https://t.co/5YRCcikgC8 pic.twitter.com/FxviG39ai2
— BBC Breaking News (@BBCBreaking) December 8, 2020
He said that this virus is deadly. We’ve got to stick by the rules.
UK Prime Minister Boris Johnson expressed gratitude toward the National Health Service (NHS) and said that “all of the scientists who worked so hard to develop this vaccine“, the volunteers and “everyone who has been following the rules to protect others. We will beat this together.”
Additionally, vaccination will not be necessary for the UK.
In light of current projections, Pfizer’s and BioNTech’s joined manufacturing network can possibly supply globally up to 50 million vaccine dosages in 2020 and up to 1.3 billion portions by the end of 2021 – subject to manufacturing limit and regulatory authorization or approval.
Pfizer stated it has set up an infrastructure to supply the vaccine around the world, including distribution hubs that can store vaccine dosages for as long as 6 months, however, the organization doesn’t expect that the product will need to be stored at any area for over 30 days because of high demand.
